View in EDS PDF Full Text

Early Reassessment of Total Metabolic Tumor Volume on FDG-PET/CT in Advanced Melanoma Patients Treated with Pembrolizumab Predicts Long-Term Outcome.

Saved in:
Bibliographic Details
Title: Early Reassessment of Total Metabolic Tumor Volume on FDG-PET/CT in Advanced Melanoma Patients Treated with Pembrolizumab Predicts Long-Term Outcome.
Authors: Vermeulen, Sim1 sim.vermeulen@uzbrussel.be, Awada, Gil1 gil.awada@uzbrussel.be, Keyaerts, Marleen1 marleen.keyaerts@uzbrussel.be, Neyns, Bart1 Bart.Neyns@uzbrussel.be, Everaert, Hendrik1 hendrik.everaert@uzbrussel.be
Source: Current Oncology. Jun2021, Vol. 28 Issue 3, p1630-1640. 11p.
Database: Academic Search Ultimate
Description
ISSN:11980052
DOI:10.3390/curroncol28030152